ZA201401481B - Viral vectors purification system - Google Patents

Viral vectors purification system

Info

Publication number
ZA201401481B
ZA201401481B ZA2014/01481A ZA201401481A ZA201401481B ZA 201401481 B ZA201401481 B ZA 201401481B ZA 2014/01481 A ZA2014/01481 A ZA 2014/01481A ZA 201401481 A ZA201401481 A ZA 201401481A ZA 201401481 B ZA201401481 B ZA 201401481B
Authority
ZA
South Africa
Prior art keywords
purification system
viral vectors
vectors purification
viral
vectors
Prior art date
Application number
ZA2014/01481A
Other languages
English (en)
Inventor
Chiara Bovolenta
Anna Stornaiuolo
Original Assignee
Molmed Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Molmed Spa filed Critical Molmed Spa
Publication of ZA201401481B publication Critical patent/ZA201401481B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/65Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression using markers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/02Recovery or purification
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/13011Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13051Methods of production or purification of viral material
    • C12N2740/13052Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/15011Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15051Methods of production or purification of viral material
    • C12N2740/15052Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/16011Human Immunodeficiency Virus, HIV
    • C12N2740/16051Methods of production or purification of viral material
    • C12N2740/16052Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ZA2014/01481A 2011-10-05 2014-02-26 Viral vectors purification system ZA201401481B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11183937 2011-10-05
PCT/EP2012/069713 WO2013050523A1 (en) 2011-10-05 2012-10-05 Viral vectors purification system

Publications (1)

Publication Number Publication Date
ZA201401481B true ZA201401481B (en) 2015-04-29

Family

ID=47071247

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2014/01481A ZA201401481B (en) 2011-10-05 2014-02-26 Viral vectors purification system

Country Status (13)

Country Link
US (1) US20140248695A1 (https=)
EP (1) EP2764094A1 (https=)
JP (1) JP2014528729A (https=)
KR (1) KR20140068259A (https=)
CN (1) CN103842501B (https=)
AU (1) AU2012320480A1 (https=)
BR (1) BR112014008225A2 (https=)
CA (1) CA2848939A1 (https=)
IL (1) IL231876A0 (https=)
IN (1) IN2014CN03368A (https=)
RU (1) RU2607044C2 (https=)
WO (1) WO2013050523A1 (https=)
ZA (1) ZA201401481B (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2480677T3 (en) 2010-09-02 2015-06-15 Molmed Spa Semi-stable production of lentiviral vectors
GB201310664D0 (en) 2013-06-14 2013-07-31 Mars Inc Feline taste receptors
BR112018070256A2 (pt) 2016-03-31 2019-01-29 Spark Therapeutics, Inc. processo de fabricação de raav totalmente escalável à base de colunas
JP2025143019A (ja) * 2024-03-18 2025-10-01 アイポア株式会社 ウイルスベクターの検査方法及び機械学習システム

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5654183A (en) * 1992-07-27 1997-08-05 California Institute Of Technology Genetically engineered mammalian neural crest stem cells
IT1261847B (it) 1993-09-01 1996-06-03 San Romanello Centro Fond Metodo per marcare cellule eucariote.
EP0781343B1 (de) * 1994-09-08 2003-07-02 Vision 7 GmbH Retrovirale vektorhybride und deren verwendung zum gentransfer
US5837520A (en) * 1995-03-07 1998-11-17 Canji, Inc. Method of purification of viral vectors
EP1284287A4 (en) * 2000-05-10 2004-10-13 Mitsubishi Pharma Corp METHOD FOR PRODUCING A VIRUS VECTOR
IL154987A0 (en) * 2000-09-22 2003-10-31 Virxsys Conditionally replicating viral vectors and their use
GB0224442D0 (en) * 2002-10-21 2002-11-27 Molmed Spa A delivery system
GB0413702D0 (en) 2004-06-18 2004-07-21 Molmed Spa Thymidine kinase
JP3968383B2 (ja) * 2004-09-01 2007-08-29 株式会社日本メディカル総研 血液細胞の新規分類法ならびにそれを利用したテイラーメード治療および予防
EP1739180A1 (en) * 2005-06-27 2007-01-03 Max-Delbrück-Centrum für Molekulare Medizin (MDC) T cell line-based packaging cell line for the production of retroviruses by enriching of CD3 expressing cells
JP4921083B2 (ja) * 2005-09-13 2012-04-18 タカラバイオ株式会社 レトロウィルス産生用無血清培地
WO2011060218A1 (en) * 2009-11-13 2011-05-19 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Modulated programmed death ligand-1
GB0920775D0 (en) * 2009-11-26 2010-01-13 King S College Cells
DK2480677T3 (en) 2010-09-02 2015-06-15 Molmed Spa Semi-stable production of lentiviral vectors
WO2012028680A1 (en) 2010-09-02 2012-03-08 Molmed Spa Semi-stable production of lentiviral vectors

Also Published As

Publication number Publication date
US20140248695A1 (en) 2014-09-04
CN103842501B (zh) 2017-12-08
IL231876A0 (en) 2014-05-28
AU2012320480A1 (en) 2014-04-24
WO2013050523A1 (en) 2013-04-11
JP2014528729A (ja) 2014-10-30
RU2014117466A (ru) 2015-11-10
KR20140068259A (ko) 2014-06-05
IN2014CN03368A (https=) 2015-07-03
EP2764094A1 (en) 2014-08-13
RU2607044C2 (ru) 2017-01-10
NZ623092A (en) 2016-07-29
BR112014008225A2 (pt) 2017-04-11
CA2848939A1 (en) 2013-04-11
CN103842501A (zh) 2014-06-04

Similar Documents

Publication Publication Date Title
ZA201400611B (en) Shelf-monitoring system
SG11201502555QA (en) Purification system
SG10201604142SA (en) Hemodialysis System
IL221158B (en) Methods for vector purification of the aav virus
EP2731756A4 (en) SYSTEM OF MANIPULATORS
GB201105902D0 (en) Location system
ZA201400381B (en) Windbreak system
ZA201404447B (en) System providing perhydrolase-catalyzed reaction
EP2719500A4 (en) PART PROCESSING SYSTEM
PL2729638T4 (pl) System mocujący
GB201111071D0 (en) Improved docking system
IL231132A0 (en) Viral cleaning methods
GB2491044B (en) Ablutionary system
SG10201606218WA (en) Purified Proteins
ZA201401657B (en) Pimping system
EP2716062A4 (en) SPEAKER SYSTEM
PL2721309T3 (pl) System mocowania
GB201102851D0 (en) Cleaning system
GB2495002B (en) Connection system
GB201400039D0 (en) Group Purchasing system
PL2663388T3 (pl) System separacji elektromembranowej
IL231876A0 (en) A system for the purification of viral vectors
PL2741811T3 (pl) Układ do leczenia objawów
GB201114353D0 (en) Loudspeaker system
ZA201401111B (en) System for strengthening poles